Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer
Status:
Terminated
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
This is a randomized phase II trial that will examine the ability of Avelumab to improve the
clinical activity of a pre-operative regimen of gemcitabine, nab-paclitaxel and
hydroxychloroquine in subjects with potentially resectable adenocarcinoma of the pancreas.